Olszynski WP - Search Results

1

A critical review of brand and generic alendronate for the treatment of osteoporosis.

Brown JP, Davison KS, Olszynski WP, Beattie KA, Adachi JD. Brown JP, et al. Among authors: olszynski wp. Springerplus. 2013 Oct 21;2(1):550. doi: 10.1186/2193-1801-2-550. eCollection 2013. Springerplus. 2013. PMID: 25674402 Free PMC article. Review.

2

Differences in In Vitro Disintegration Time among Canadian Brand and Generic Bisphosphonates.

Olszynski WP, Adachi JD, Davison KS. Olszynski WP, et al. J Osteoporos. 2014;2014:420451. doi: 10.1155/2014/420451. Epub 2014 Oct 2. J Osteoporos. 2014. PMID: 25349772 Free PMC article.

3

Alendronate for the treatment of osteoporosis in men.

Olszynski WP, Davison KS. Olszynski WP, et al. Expert Opin Pharmacother. 2008 Feb;9(3):491-8. doi: 10.1517/14656566.9.3.491. Expert Opin Pharmacother. 2008. PMID: 18220499 Review.

4

Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment.

Olszynski WP, Shawn Davison K, Adachi JD, Brown JP, Cummings SR, Hanley DA, Harris SP, Hodsman AB, Kendler D, McClung MR, Miller PD, Yuen CK. Olszynski WP, et al. Clin Ther. 2004 Jan;26(1):15-28. doi: 10.1016/s0149-2918(04)90002-1. Clin Ther. 2004. PMID: 14996514 Review.

5

Are there differences between men and women prescribed bisphosphonate therapy in canadian subspecialty osteoporosis practices?

Sawka AM, Adachi JD, Papaioannou A, Thabane L, Ioannidis G, Davison KS, Olszynski WP, Brown JP, Hanley DA, Murray TM, Josse RG, Sebaldt RJ, Petrie A, Tenenhouse A, Goldsmith CH. Sawka AM, et al. Among authors: olszynski wp. J Rheumatol. 2004 Oct;31(10):1993-5. J Rheumatol. 2004. PMID: 15468365

6

Multisite quantitative ultrasound for the prediction of fractures over 5 years of follow-up: the Canadian Multicentre Osteoporosis Study.

Olszynski WP, Brown JP, Adachi JD, Hanley DA, Ioannidis G, Davison KS; CaMos Research Group. Olszynski WP, et al. J Bone Miner Res. 2013 Sep;28(9):2027-34. doi: 10.1002/jbmr.1931. J Bone Miner Res. 2013. PMID: 23519952 Free PMC article.

7

Normative data for multisite quantitative ultrasound: the Canadian Multicenter Osteoporosis Study.

Olszynski WP, Brown JP, Adachi JD, Hanley DA, Ioannidis G, Davison KS; CaMos Research Group. Olszynski WP, et al. J Clin Densitom. 2014 Oct-Dec;17(4):534-40. doi: 10.1016/j.jocd.2013.09.017. Epub 2013 Oct 26. J Clin Densitom. 2014. PMID: 24169082

8

Comparison of Speed of Sound Measures Assessed by Multisite Quantitative Ultrasound to Bone Mineral Density Measures Assessed by Dual-Energy X-Ray Absorptiometry in a Large Canadian Cohort: the Canadian Multicentre Osteoporosis Study (CaMos).

Olszynski WP, Adachi JD, Hanley DA, Davison KS, Brown JP. Olszynski WP, et al. J Clin Densitom. 2016 Apr-Jun;19(2):234-41. doi: 10.1016/j.jocd.2015.04.004. Epub 2015 Jun 6. J Clin Densitom. 2016. PMID: 26050876

9

Change in Quantitative Ultrasound-assessed Speed of Sound as a Function of Age in Women and Men and Association With the Use of Antiresorptive Agents: The Canadian Multicentre Osteoporosis Study.

Olszynski WP, Davison KS, Adachi JD, Brown JP, Hanley DA. Olszynski WP, et al. J Clin Densitom. 2020 Oct-Dec;23(4):549-560. doi: 10.1016/j.jocd.2019.10.001. Epub 2019 Oct 9. J Clin Densitom. 2020. PMID: 31735596

10

Management of corticosteroid-induced osteoporosis.

Adachi JD, Olszynski WP, Hanley DA, Hodsman AB, Kendler DL, Siminoski KG, Brown J, Cowden EA, Goltzman D, Ioannidis G, Josse RG, Ste-Marie LG, Tenenhouse AM, Davison KS, Blocka KL, Pollock AP, Sibley J. Adachi JD, et al. Among authors: olszynski wp. Semin Arthritis Rheum. 2000 Feb;29(4):228-51. doi: 10.1016/s0049-0172(00)80011-6. Semin Arthritis Rheum. 2000. PMID: 10707991 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters